ArticleAnnals of hematology2022

Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real-world, multi-center, matched analysis.

Shai Shimony et al.PubMed ↗Publisher ↗

No numbers read from the abstract.